Identifying Antibodies that Target Tumor Cells
Author Information
Author(s): Monaci Paolo, Luzzago Alessandra, Santini Claudia, De Pra Alessandra, Arcuri Mirko, Magistri Francesca, Bellini Alessandro, Ansuini Helenia, Ambrosio Maria, Ammendola Virginia, Bigotti Maria Giulia, Cirillo Agostino, Nuzzo Maurizio, Nasti Annamaria Assunta, Neuner Philippe, Orsatti Laura, Pezzanera Monica, Sbardellati Andrea, Silvestre Giuseppe, Uva Paolo, Viti Valentina, Barbato Gaetano, Colloca Stefano, Demartis Anna, De Rinaldis Emanuele, Giampaoli Saverio, Lahm Armin, Palombo Fabio, Talamo Fabio, Vitelli Alessandra, Nicosia Alfredo, Cortese Riccardo
Primary Institution: Istituto di Ricerca di Biologia Molecolare (IRBM) P. Angeletti
Hypothesis
Can a novel tagArray technology efficiently identify antibodies that bind to tumor-specific receptors?
Conclusion
The study successfully developed a tagArray technology that identifies antibodies binding to tumor-specific receptors, demonstrating potential for therapeutic applications.
Supporting Evidence
- The tagArray technology allows for the identification of antibodies binding to tumor-specific receptors.
- Phage-Abs were shown to inhibit cell proliferation in vitro and tumor development in vivo.
- Five different mAbs were identified that target the transferrin receptor, which is over-expressed in various cancers.
Takeaway
Researchers created a new method to find antibodies that stick to cancer cells, which could help in developing better cancer treatments.
Methodology
The study used a tagArray technology to screen a collection of phage-displayed antibodies against tumor and normal tissues to identify tumor-specific antibodies.
Participant Demographics
Two colorectal cancer patients were involved in the study.
Statistical Information
P-Value
p<3×10−5
Statistical Significance
p<3×10−5
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website